Tag: InterShunt

InterShunt Technologies Announces Expansion of Board of Directors and Opening of Minneapolis Facility

PLYMOUTH, Minn., Feb. 9, 2021 /PRNewswire/ — InterShunt Technologies, Inc., an early-stage medical device company developing a novel catheter-based solution to reduce left atrial pressure in heart failure patients, announced today the appointment of key members to the company’s Board of Directors.  Jim Bullock, David Adair, MD, MBA, and Denis Harrington join current Board Directors Harlee Sorkin, CEO […]

InterShunt Announces Equity Financing

ST. LOUIS, Jan. 11, 2021 /PRNewswire/ — InterShunt Technologies, Inc., an early-stage medical device company developing a novel catheter-based solution to reduce left atrial pressure in heart failure patients, announced today the completion of an equity financing. Funding will be used to support the research and development of the Percutaneous Atrial Shunt Catheter […]

InterShunt Technologies Announces Formation and Initial Meeting of its Scientific Advisory Board to Guide Development of its Percutaneous Atrial Shunt Catheter System for Heart Failure

ST. LOUIS, April 28, 2020 /PRNewswire/ — InterShunt Technologies, Inc., an early stage medical device company developing a novel catheter-based solution to reduce left atrial pressure in heart failure patients, today announced the formation of a Scientific Advisory Board and successful first meeting. Amid the Coronavirus restrictions, InterShunt conducted its inaugural meeting by […]